India Pharma Outlook Team | Tuesday, 09 January 2024
The Mayo Clinic, a nonprofit medical center in Rochester, Minnesota, has announced a partnership with Silicon Valley startup Cerebras Systems to build artificial intelligence (AI) models for the healthcare business.
The Mayo Clinic, which has three major campuses in the US in addition to locations in the UK and the United Arab Emirates, will use computing chips and systems from Cerebras to tap into decades of anonymised medical records and data to develop its own AI models, as per economic times.
Matthew Callstrom, Mayo's medical director for strategy and chair of its radiology department, stated that some of the models will be able to read and write text, allowing them to summarize the most relevant elements of a lengthy medical record for a new patient.
Other models will be able to examine photographs for patterns that educated medical specialists' eyes may miss, as well as evaluate genetic data. Medical decisions will continue to be made by doctors, not the systems themselves.
"How do you make the right decision for each patient? You have to weigh all those factors, you have to have a lot of experience. That's where AI comes in to start to augment that," Callstrom added.
Mayo intends to make the results of its collaboration with Cerebras available on its Mayo Clinic Platform, a data network shared by the Mercy health care system in the United States, the University Health Network in Canada, as well as systems in Brazil and Israel.
Callstrom stated that Mayo has not yet decided how much it will charge for the AI technology. The clinic intended to announce the new initiative during a talk at JPMorgan Chase's health-care conference in San Francisco.